Last Updated on June 22, 2023

Current Enzyme Inhibition- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Bentham Science Publishers B.V.

Abbreviation: Curr. Enzyme Inhib.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

0.71

SJR

 0.174

h-Index

 18

Rank

 20529

Important Details

Title Current Enzyme Inhibition
Standard Abbreviation Curr. Enzyme Inhib.
Type of Publication Journal
Discipline Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)
Impact Score 0.71
SCImago Journal Rank (SJR) 0.174
h-index 18
Overall Rank 20529
Publisher Name Bentham Science Publishers B.V.
Publication Country United Arab Emirates
International Standard Serial Number (ISSN) 15734080
Coverage and History 2006-2022
Best Quartile Q4
Total Citations Received
(Last 3 Year)
46

About Current Enzyme Inhibition


Current Enzyme Inhibition is a journal published by Bentham Science Publishers B.V.. This journal covers the area[s] related to Biochemistry, Drug Discovery, Molecular Medicine, etc. The coverage history of this journal is as follows: 2006-2022. The rank of this journal is 20529. This journal's impact score, h-index, and SJR are 0.71, 18, and 0.174, respectively. The ISSN of this journal is/are as follows: 15734080.

The best quartile of Current Enzyme Inhibition is Q4. This journal has received a total of 46 citations during the last three years (Preceding 2022).


Current Enzyme Inhibition Impact Score 2022-2023


The latest impact score (IS) of the Current Enzyme Inhibition is 0.71. It is computed in the year 2023 as per its definition and based on Scopus data. 0.71

It is increased by a factor of around 0.01, and the percentage change is 1.43% compared to the preceding year 2021, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Current Enzyme Inhibition Impact Score 2023


Impact Score 2022 of Current Enzyme Inhibition is 0.71. If a similar upward trend continues, IS may increase in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Current Enzyme Inhibition. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.71
2021 0.70
2020 0.40
2019 0.68
2018 0.34
2017 0.65
2016 0.33
2015 0.24
2014 0.43

Current Enzyme Inhibition h-index


  Table Setting

The h-index of Current Enzyme Inhibition is 18. By definition of the h-index, this journal has at least 18 published articles with more than 18 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Current Enzyme Inhibition ISSN


The International Standard Serial Number (ISSN) of Current Enzyme Inhibition is/are as follows: 15734080.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Current Enzyme Inhibition Ranking and SCImago Journal Rank (SJR)


The Current Enzyme Inhibition is ranked 20529 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.174.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Current Enzyme Inhibition Publisher


Table Setting

The publisher of Current Enzyme Inhibition is Bentham Science Publishers B.V.. The publishing house of this journal is located in the United Arab Emirates. Its coverage history is as follows: 2006-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Current Enzyme Inhibition is Curr. Enzyme Inhib.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Curr. Enzyme Inhib.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Current Enzyme Inhibition


If your area of research or discipline is related to Biochemistry, Drug Discovery, Molecular Medicine, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Current Enzyme Inhibition?

The latest impact score of Current Enzyme Inhibition is 0.71. It is computed in the year 2023.


What is the h-index of Current Enzyme Inhibition?

The latest h-index of Current Enzyme Inhibition is 18. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Current Enzyme Inhibition?

The latest SCImago Journal Rank (SJR) of Current Enzyme Inhibition is 0.174. It is calculated in the year 2023.


What is the ranking of Current Enzyme Inhibition?

The latest ranking of Current Enzyme Inhibition is 20529. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Current Enzyme Inhibition?

Current Enzyme Inhibition is published by Bentham Science Publishers B.V.. The publication country of this journal is United Arab Emirates.


What is the abbreviation of Current Enzyme Inhibition?

This standard abbreviation of Current Enzyme Inhibition is Curr. Enzyme Inhib..


Is "Current Enzyme Inhibition" a Journal, Conference or Book Series?

Current Enzyme Inhibition is a journal published by Bentham Science Publishers B.V..


What is the scope of Current Enzyme Inhibition?

The scope of Current Enzyme Inhibition is as follows:

  • Biochemistry
  • Drug Discovery
  • Molecular Medicine

For detailed scope of Current Enzyme Inhibition, check the official website of this journal.


What is the ISSN of Current Enzyme Inhibition?

The International Standard Serial Number (ISSN) of Current Enzyme Inhibition is/are as follows: 15734080.


What is the best quartile for Current Enzyme Inhibition?

The best quartile for Current Enzyme Inhibition is Q4.


What is the coverage history of Current Enzyme Inhibition?

The coverage history of Current Enzyme Inhibition is as follows 2006-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
European Union Politics Journal SAGE Publications Ltd 2250 72 2.64
Journal of Field Archaeology Journal Maney Publishing 5639 43 2.38
Socialism and Democracy Journal Taylor and Francis Ltd. 26162 17 0.09
SPE International Formation Damage Control Symposium Proceedings Conference And Proceedings 21934 16 0.00
Engenharia Agricola Journal Sociedade Brasileira de Engenharia Agricola 15839 30 1.12
Metascience Journal Springer Nature 13645 3 0.13
HOMO- Journal of Comparative Human Biology Journal Elsevier BV 19810 35 0.56
Chemical Product and Process Modeling Journal Walter de Gruyter GmbH 20431 19 1.26
Current Protocols in Molecular Biology Journal John Wiley & Sons Inc. 1659 51 2.95
Economics of Innovation and New Technology Journal Routledge 6153 62 3.55

Check complete list




Current Enzyme Inhibition Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 0.71
2021 0.70
2020 0.40
2019 0.68
2018 0.34
2017 0.65
2016 0.33
2015 0.24
2014 0.43



Top Journals/Conferences in Biochemistry

Cell
Cell Press | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Nature Methods
Nature Publishing Group | United Kingdom

Nature Catalysis
Nature Publishing Group | United States

Annual Review of Biochemistry
Annual Reviews Inc. | United States

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

Nature Reviews Methods Primers
Springer Nature | United States

Annual Review of Biophysics
Annual Reviews Inc. | United States

Chem
Elsevier Inc. | United States

Nature Protocols
Nature Publishing Group | United Kingdom

Annals of the Rheumatic Diseases
BMJ Publishing Group | United Kingdom

Molecular Systems Biology
Wiley-Blackwell | United States

Journal of the American Chemical Society
American Chemical Society | United States

Cell Reports Medicine
Cell Press | United States

EMBO Journal
Wiley-Blackwell | Germany

See All

Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

Expert Opinion on Therapeutic Targets
Taylor and Francis Ltd. | United Kingdom

Nucleic Acid Therapeutics
Mary Ann Liebert Inc. | United States

Drug Discovery Today
Elsevier Ltd. | United Kingdom

Current Opinion in Systems Biology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Biomarker Research
BioMed Central Ltd. | United Kingdom

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

See All